$CARL News

Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026

Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System

BTIG Maintains Buy on Carlsmed, Raises Price Target to $24

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

Carlsmed names new CFO

Carlsmed Appoints Richard Heppenstall as Chief Financial Officer

BTIG Reiterates Buy on Carlsmed, Maintains $23 Price Target

Carlsmed Affirms FY2026 Sales Guidance of $74.000M-$78.000M vs $74.830M Est

Carlsmed Appoints Richard Heppenstall CFO, Succeeding Leo Greenstein; Co. Reiterates FY26 Revenue Range Of $74M - $78M

Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical

Carlsmed, Inc. Announces Chief Operating Officer Appointment

Carlsmed Files Prospectus To Offer Up To $250M In Securities

Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform

Carlsmed, Inc. (CARL) Presents at Bank of America SMID Cap Virtual Conference Transcript

Truist Securities Maintains Buy on Carlsmed, Raises Price Target to $20

Carlsmed Inc (CARL) (Q2 2026) Earnings Call Highlights: Revenue Surges 57% to $18. ...

Carlsmed Q2 Earnings Call Highlights

Carlsmed, Inc. (CARL) Q2 2026 Earnings Call Transcript

Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance